Antimicrobial Resistance and Inorganic Nanoparticles
| Autor: | Claudia-Adriana Ramírez-Valdespino, Linda-Lucila Landeros-Martínez, Erasmo Orrantia-Borunda, Andrea-Sarahí Balderrama-González, Hilda-Amelia Piñón-Castillo, Hilda-Esperanza Esparza-Ponce |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
medicine.drug_class
QH301-705.5 Antibiotics Review Catalysis Microbiology Inorganic Chemistry Antibiotic resistance Drug Resistance Bacterial medicine Humans In patient antimicrobial resistance Physical and Theoretical Chemistry Biology (General) bacteria Molecular Biology QD1-999 Spectroscopy Drug Carriers biology Chemistry Organic Chemistry High mortality Antibiotic exposure Bacterial Infections General Medicine biology.organism_classification Antimicrobial Anti-Bacterial Agents Computer Science Applications Inorganic Chemicals nanoparticles Inorganic nanoparticles Bacteria resistance mechanism |
| Zdroj: | International Journal of Molecular Sciences, Vol 22, Iss 12890, p 12890 (2021) International Journal of Molecular Sciences |
| ISSN: | 1661-6596 1422-0067 |
| Popis: | Antibiotics are being less effective, which leads to high mortality in patients with infections and a high cost for the recovery of health, and the projections that are had for the future are not very encouraging which has led to consider antimicrobial resistance as a global health problem and to be the object of study by researchers. Although resistance to antibiotics occurs naturally, its appearance and spread have been increasing rapidly due to the inappropriate use of antibiotics in recent decades. A bacterium becomes resistant due to the transfer of genes encoding antibiotic resistance. Bacteria constantly mutate; therefore, their defense mechanisms mutate, as well. Nanotechnology plays a key role in antimicrobial resistance due to materials modified at the nanometer scale, allowing large numbers of molecules to assemble to have a dynamic interface. These nanomaterials act as carriers, and their design is mainly focused on introducing the temporal and spatial release of the payload of antibiotics. In addition, they generate new antimicrobial modalities for the bacteria, which are not capable of protecting themselves. So, nanoparticles are an adjunct mechanism to improve drug potency by reducing overall antibiotic exposure. These nanostructures can overcome cell barriers and deliver antibiotics to the cytoplasm to inhibit bacteria. This work aims to give a general vision between the antibiotics, the nanoparticles used as carriers, bacteria resistance, and the possible mechanisms that occur between them. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|